Old Web
English
Sign In
Acemap
>
authorDetail
>
Hongmei Li
Hongmei Li
Bristol-Myers Squibb
Dapagliflozin
Medicine
Urine
Excretion
Pharmacodynamics
2
Papers
136
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dapagliflozin as Monotherapy in Drug-Naive Asian Patients With Type 2 Diabetes Mellitus: A Randomized, Blinded, Prospective Phase III Study
2014
Clinical Therapeutics
Linong Ji
Jianhua Ma
Hongmei Li
Traci A Mansfield
Caroline L. T’joen
Nayyar Iqbal
Agata Ptaszynska
James F. List
Show All
Source
Cite
Save
Citations (114)
Pharmacokinetic and Pharmacodynamic Properties of Single- and Multiple-Dose of Dapagliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese Subjects
2013
Clinical Therapeutics
Li Yang
Haiyan Li
Hongmei Li
Anh Bui
Ming Chang
Xiaoni Liu
Sreeneeranj Kasichayanula
Steven C. Griffen
Frank LaCreta
David W. Boulton
Show All
Source
Cite
Save
Citations (22)
1